United Well

United Well is an innovation-driven biotech enterprise specializing in radiopharmaceutical R&D and international translation. Focused on “Theranostics” — the integration of diagnosis and therapy — the company addresses major unmet needs in oncology and neurodegenerative diseases. With dual R&D hubs in China and the U.S.,United Well has established a full-chain capability platform encompassing drug design,isotope conjugation,GMP process development, quality control, and global registration. Multinational clinical trials and commercialization strategies are now being deployed across Europe, North America, and Asia-Pacific.